Nestlé Moves Further Into Health, Buying Peanut-Allergy Treatment Maker – The Wall Street Journal
Capsules of peanut-allergy treatment Palforzia, manufactured by Aimmune Therapeutics. Photo: aimmune therapeutics/Reuters By Olivia Bugault Close Olivia Bugault Biography olivia.bugault@wsj.com Updated Aug. 31, 2020 9:55 am ET Nestlé SA NSRGY -0.01% said it agreed to buy Aimmune Therapeutics Inc., AIMT 171.19% a biopharmaceutical company that earlier this year won approval for the first treatment for… Read More »